other material
confidence high
sentiment positive
materiality 0.65
Liminatus Pharma exchanges 1M warrants for 350K shares with Alta Partners
Liminatus Pharma, Inc.
- Company issued 350,000 shares of common stock to Alta Partners in exchange for surrender and cancellation of 1,000,000 warrants.
- No commission or other remuneration was paid in connection with the exchange.
- Shares were issued in reliance on the Section 3(a)(9) exemption from registration.
- The transaction reduces potential dilution from outstanding warrants by 650,000 shares on a net basis.